Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-month therapeutic effect of pudendal nerve infiltrations in pudendal neuralgia due to canal syndrome
2008-003914-87Phase 4Active
- Sponsor
- CHU de Nantes
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylprednisolone in pudendal neuralgia (PN) and Pudendal canal entrapment syndrome (PCES) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Pain intensity at 3 months. Started Oct 2008; status: active.
02
Drugs
methylprednisolone
03
Conditions
pudendal neuralgia (PN)Pudendal canal entrapment syndrome (PCES)
Beyond the preview
Go deeper on 2008-003914-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003914-87.